Grufity logoGrufity logo

HUM

546.35USD-1.07(-0.20%)Market Closed

Humana Inc

Market Summary

USD546.35-1.07Market Closed
-0.20%

HUM Alerts

HUM Stock Price

RSI Chart

Valuation

Market Cap

70.2B

Price/Earnings

22.34

Price/Sales

0.79

Price/Cashflow

17.55

MarketCap/EBT

17.88

Price/Sales

Profitability

EBT Margin

4.39%

Return on Equity

20.26%

Return on Assets

6.71%

Fundamentals

Revenue

Revenue (TTM)

91.5B

Revenue Y/Y

10.16%

Revenue Q/Q

-3.65%

Earnings

Earnings (TTM)

2.8B

Earnings Y/Y

-21.95%

Earnings Q/Q

71.7%

Price Action

52 Week Range

351.20571.30
(Low)(High)

Last 7 days

2.5%

Last 30 days

-1.0%

Last 90 days

13.4%

Trailing 12 Months

27.0%

Financial Health

Current Ratio

1.53

Investor Care

Dividend Yield

0.54%

Dividend/Share (TTM)

2.73

Buy Backs (1Y)

1.50%

Diluted EPS (TTM)

22.06

Peers (Alternatives to Humana)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
515.6B
253.8B
0.21% 18.35%
28.25
1.68
-9.15% 25.96%
99.1B
47.5B
2.33% 61.02%
17.89
0.55
-72.06% -32.36%
70.2B
91.5B
-1.03% 26.96%
22.34
0.79
12.84% 5.01%
48.9B
141.6B
5.14% 19.73%
24.29
0.35
16.31% 173.64%
MID-CAP
6.5B
795.1M
-13.94% 15.88%
-103.91
8.12
7.32% -8695.99%
5.5B
5.5B
4.43% 5.74%
11.91
1.05
68.51% 117.01%
5.2B
2.3B
-2.08% 37.64%
54.18
2.25
7.63% -28.34%
2.8B
669.9M
-7.81% -24.07%
42.62
4.21
16.37% 20.70%
2.6B
6.4B
6.08% 0.39%
13.33
0.4
0.12% 24.54%
SMALL-CAP
1.7B
928.7M
-2.31% 19.24%
38.16
1.87
11.11% 9.39%
1.6B
500.7M
0.59% 17.88%
18.77
3.24
-11.66% 1451.89%
1.1B
1.4B
22.95% -26.90%
47.05
0.81
6.94% -77.50%
849.9M
2.8B
-29.59% -48.40%
-9.25
0.32
-6.67% -377.23%

Financials for Humana

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue2.4%91,48589,38386,36683,06481,072
  S&GA Expenses3.8%12,51512,05711,00010,1219,794
Earnings Before Taxes-8.7%3,5793,9183,5343,3542,956
Net Income-10.7%2,8073,1433,0352,9332,673
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets8.4%50,76546,82046,30844,35845,320
  Current Assets23.9%33,71127,21726,84024,89325,815
    Cash Equivalents163.1%13,5585,1534,8643,3944,304
  Net PPE3.1%3,2183,1213,1893,0732,898
  Goodwill2.1%9,0968,91111,13911,09210,806
Liabilities10.0%34,44831,31030,96628,25529,038
  Current Liabilities40.4%25,05117,83917,53215,33115,027
    LT Debt, Non Current-30.9%7,79811,29011,28510,54111,466
Shareholder's Equity5.2%16,31715,51015,34216,10316,282
  Retained Earnings4.5%25,60624,51123,91523,08623,191
  Additional Paid-In Capital2.6%3,2343,1533,1033,0823,064
Accumulated Depreciation-2,874----
Shares Outstanding0.0%127127126129-
Minority Interest215.0%6320232322
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations140.5%9,6184,0003,4012,2622,641
  Share Based Compensation16.9%221189184180184
Cashflow From Investing98.4%-96.00-6,023.00-5,716.00-6,556.00-6,509.00
Cashflow From Financing-106.9%-268.003,8653,3023,015187
  Dividend Payments2.7%382372362354347
  Buy Backs0.1%1,0751,0741,073791,826

Risks

What is the probability of a big loss on HUM?

57.7%


Probability that Humana stock will be more than 20% underwater in next one year

19.2%


Probability that Humana stock will be more than 30% underwater in next one year.

0%


Probability that Humana stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does HUM drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Humana was unfortunately bought at previous high price.

Returns

Cumulative Returns on HUM

24.4%


10-Year Cumulative Returns

18.9%


7-Year Cumulative Returns

17.3%


5-Year Cumulative Returns

16.9%


3-Year Cumulative Returns

What are the long-term rolling returns for HUM?

FIve years rolling returns for Humana.

Which funds bought or sold HUM recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-23
Eagle Bay Advisors LLC
REDUCED
-1.73
5,307
303,000
0.19%
2022-11-23
Toroso Investments, LLC
REDUCED
-4.71
-50,000
4,057,000
0.17%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
5,869,000
5,869,000
0.07%
2022-11-22
CVA Family Office, LLC
UNCHANGED
-
4,000
107,000
0.03%
2022-11-22
B. Riley Wealth Advisors, Inc.
ADDED
48.35
236,000
675,000
0.02%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
REDUCED
-1.17
2,465,000
103,441,000
0.17%
2022-11-21
FourThought Financial, LLC
NEW
-
3,000
3,000
-%
2022-11-18
National Pension Service
ADDED
0.37
5,023,000
99,734,000
0.21%
2022-11-18
Industrial Alliance Investment Management Inc.
NEW
-
251,000
251,000
0.01%
2022-11-17
CENTRAL TRUST Co
ADDED
23.4
31,000
141,000
-%

1–10 of 43

Latest Funds Activity

Are funds buying HUM calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own HUM

Humana News

Yahoo Eurosport UK

Humana Inc. (NYSE:HUM) insiders sold US$12m worth of stock suggesting impending weakness..9 hours ago

HUM Fair Value

Recent SEC filings of Humana

View All Filings
Date Filed Form Type Document
Nov 22, 2022
8-K
Current Report
Nov 08, 2022
8-K
Current Report
Nov 08, 2022
424B5
Prospectus Filed
Nov 08, 2022
FWP
Prospectus Filed
Nov 07, 2022
4
Insider Trading
Nov 07, 2022
4
Insider Trading
Nov 07, 2022
4
Insider Trading
Nov 07, 2022
424B5
Prospectus Filed
Nov 07, 2022
4
Insider Trading
Nov 07, 2022
4
Insider Trading

Latest Insider Trading transactions for HUM

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-04
Diamond Susan M
GIFTED
-
-
-100
Chief Financial Officer
2022-11-03
Deshpande Samir
ACQUIRED
2,736,950
291.103
9,402
Chief Information Officer
2022-11-03
Deshpande Samir
SOLD FOR TAXES
-399,940
560.14
-714
Chief Information Officer
2022-11-03
Ventura Joseph C
SOLD FOR TAXES
-299,675
560.14
-535
Chief Legal Officer
2022-11-03
Fleming William Kevin
ACQUIRED
3,619,970
324.458
11,157
Seg Pres, Pharmacy Sol & CCAO
2022-11-03
BROUSSARD BRUCE D
SOLD FOR TAXES
-17,245,000
560.14
-30,787
President & CEO
2022-11-03
Ventura Joseph C
ACQUIRED
1,106,210
307.965
3,592
Chief Legal Officer
2022-11-03
Fleming William Kevin
SOLD
-6,310,550
565.614
-11,157
Seg Pres, Pharmacy Sol & CCAO
2022-11-03
Deshpande Samir
SOLD
-4,506,120
565.953
-7,962
Chief Information Officer
2022-11-03
Diamond Susan M
ACQUIRED
1,422,800
360.658
3,945
Chief Financial Officer

1–10 of 50

Bruce D. Broussard
65535
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

HUM Income Statement

2022-09-30
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
$ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Services revenue, typeHealth Care [Member]Health Care [Member]Health Care [Member]Health Care [Member]
Revenues:    
Premiums$ 21,468$ 19,885$ 66,437$ 59,987
Services1,1598453,7721,802
Investment income (loss)172(33)222221
Total revenues22,79920,69770,43162,010
Operating expenses:    
Benefits18,38417,31657,10851,761
Operating costs3,0612,6039,1206,726
Depreciation and amortization182150527436
Total operating expenses21,62720,06966,75558,923
Income (loss) from operations1,1726283,6763,087
Gain on sale of KAH Hospice(240)0(240)0
Interest expense10288293235
Other expense (income), net13(1,096)(16)(562)
Income (loss) before income taxes and equity in net earnings1,2971,6363,6393,414
Provision for income taxes107120820536
Equity in net earnings315169
Net income1,1931,5312,8202,947
Net loss attributable to noncontrolling interests2010
Net income attributable to Humana$ 1,195$ 1,531$ 2,821$ 2,947
Basic earnings per common share (in dollars per share)$ 9.45$ 11.91$ 22.27$ 22.90
Diluted earnings per common share (in dollars per share)$ 9.39$ 11.84$ 22.16$ 22.77

HUM Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 13,558$ 3,394
Investment securities13,12413,192
Receivables, net of allowances of $71 in 2022 and $83 in 20211,6091,814
Other current assets5,4206,493
Total current assets33,71124,893
Property and equipment, net3,2183,073
Long-term investment securities375780
Equity method investments738141
Goodwill9,09611,092
Other long-term assets3,6274,379
Total assets50,76544,358
Current liabilities:  
Benefits payable9,2378,289
Trade accounts payable and accrued expenses6,7664,509
Book overdraft237326
Unearned revenues6,012254
Short-term debt2,7991,953
Total current liabilities25,05115,331
Long-term debt7,79810,541
Other long-term liabilities1,5992,383
Total liabilities34,44828,255
Stockholders’ equity:  
Preferred stock, $1 par; 10,000,000 shares authorized; none issued00
Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at September 30, 2022 and 198,648,742 shares at December 31, 20213333
Capital in excess of par value3,2343,082
Retained earnings25,60623,086
Accumulated other comprehensive (loss) income(1,467)42
Treasury stock, at cost, 72,066,280 shares at September 30, 2022 and 69,846,758 shares at December 31, 2021(11,152)(10,163)
Noncontrolling interests6323
Total stockholders’ equity16,31716,103
Total liabilities and stockholders’ equity$ 50,765$ 44,358